Literature DB >> 17337778

Pneumocystis colonization, airway inflammation, and pulmonary function decline in acquired immunodeficiency syndrome.

Karen A Norris1, Alison Morris, Sangita Patil, Eustace Fernandes.   

Abstract

As a result of improved diagnosis, treatment, and supportive care for HIV-infected patients, AIDS in developed countries has now become a chronic infection with prolonged survival time, but longterm complications are increasing contributors to morbidity and mortality. HIV-infected patients are at increased risk for the development of pulmonary complications, including chronic obstructive pulmonary disease (COPD); however, the mechanisms associated with this increased susceptibility have not been defined. Infectious agents may contribute to the development of COPD by upregulating inflammatory mediators in the lung that act in concert with cigarette smoke to promote lung pathology. Studies in human subjects and non-human primate models of AIDS suggest that the inflammatory response to asymptomatic carriage or colonization by the opportunistic pathogen, Pneumocystis sp. (Pc), is similar to that of COPD, which is characterized by influx of CD8+ T cells, neutrophils, and macrophages into the lungs. We have shown a high frequency of Pc colonization among asymptomatic HIV-infected subjects and in non-HIV infected subjects with COPD. To investigate the role of Pc in the progression of obstructive lung disease in HIV infections, we developed a non-human primate model of Pc colonizatoin and infection in simian immunodeficiency virus (SIV)-infected macaques. These animals develop a prolonged colonization state characterized by a persistent influx of CD8+ T cells and neutrophils, and local increases in IL-8, IFN-gamma, and TNF-alpha. SIV-infected Pc-colonized monkeys show progressive decline in pulmonary function compared to SIV-infected monkeys. We hypothesize that in the context of AIDS-immune dysfunction, Pc colonization induces inflammatory responses leading to changes in pulmonary function and architecture similar to that seen in emphysema. Information gained from these studies will lead to the development of interventions to prevent lung injury associated with Pc colonization and the development of HIV-associated COPD.

Entities:  

Mesh:

Year:  2006        PMID: 17337778     DOI: 10.1385/IR:36:1:175

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  45 in total

1.  Detection of rat Pneumocystis carinii proteinases and elastase and antipneumocystis activity of proteinase inhibitors in vitro.

Authors:  C Atzori; A Mainini; F Agostoni; E Angeli; M Bartlett; A Bruno; M Scaglia; A Cargnel
Journal:  Parasite       Date:  1999-03       Impact factor: 3.000

2.  Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysematous patients.

Authors:  G A Finlay; K J Russell; K J McMahon; E M D'arcy; J B Masterson; M X FitzGerald; C M O'Connor
Journal:  Thorax       Date:  1997-06       Impact factor: 9.139

Review 3.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

Review 4.  Respiratory mechanics in infants: physiologic evaluation in health and disease. American Thoracic Society/European Respiratory Society.

Authors: 
Journal:  Am Rev Respir Dis       Date:  1993-02

Review 5.  Airway inflammation in chronic obstructive pulmonary disease.

Authors:  M Saetta
Journal:  Am J Respir Crit Care Med       Date:  1999-11       Impact factor: 21.405

6.  Pneumocystis carinii carriage among cystic fibrosis patients, as detected by nested PCR.

Authors:  A Sing; A M Geiger; M Hogardt; J Heesemann
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

7.  Pneumocystis carinii carriage in immunocompetent patients with primary pulmonary disorders as detected by single or nested PCR.

Authors:  A Sing; A Roggenkamp; I B Autenrieth; J Heesemann
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

8.  Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study.

Authors:  N A Maskell; D J Waine; A Lindley; J C T Pepperell; A E Wakefield; R F Miller; R J O Davies
Journal:  Thorax       Date:  2003-07       Impact factor: 9.139

9.  Collagenase expression in the lungs of transgenic mice causes pulmonary emphysema.

Authors:  J D'Armiento; S S Dalal; Y Okada; R A Berg; K Chada
Journal:  Cell       Date:  1992-12-11       Impact factor: 41.582

10.  Association between human-Pneumocystis infection and small-cell lung carcinoma.

Authors:  C de la Horra; J M Varela; J Fernández-Alonso; F J Medrano; N Respaldiza; M A Montes-Cano; E J Calderón
Journal:  Eur J Clin Invest       Date:  2004-03       Impact factor: 4.686

View more
  23 in total

1.  Pneumocystis workshop: 10th anniversary summary.

Authors:  James M Beck; Melanie T Cushion
Journal:  Eukaryot Cell       Date:  2009-01-23

2.  Trimethoprim-sulfamethoxazole treatment does not reverse obstructive pulmonary changes in pneumocystis-colonized nonhuman primates with SHIV infection.

Authors:  Heather M Kling; Timothy W Shipley; Siobhan Guyach; Rebecca Tarantelli; Alison Morris; Karen A Norris
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

Review 3.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

Review 4.  HIV and chronic obstructive pulmonary disease: is it worse and why?

Authors:  Alison Morris; M Patricia George; Kristina Crothers; Laurence Huang; Lorrie Lucht; Cathy Kessinger; Eric C Kleerup
Journal:  Proc Am Thorac Soc       Date:  2011-06

Review 5.  An official ATS workshop report: Emerging issues and current controversies in HIV-associated pulmonary diseases.

Authors:  Alison Morris; Kristina Crothers; James M Beck; Laurence Huang
Journal:  Proc Am Thorac Soc       Date:  2011-03

6.  Pneumocystis infection and the pathogenesis of chronic obstructive pulmonary disease.

Authors:  Karen A Norris; Alison Morris
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

7.  MyD88 signaling regulates both host defense and immunopathogenesis during pneumocystis infection.

Authors:  Sheila N Bello-Irizarry; Jing Wang; Carl J Johnston; Francis Gigliotti; Terry W Wright
Journal:  J Immunol       Date:  2013-11-29       Impact factor: 5.422

8.  Airway obstruction is increased in pneumocystis-colonized human immunodeficiency virus-infected outpatients.

Authors:  Alison Morris; Travis Alexander; Saba Radhi; Lorrie Lucht; Frank C Sciurba; Jay K Kolls; Ruma Srivastava; Chad Steele; Karen A Norris
Journal:  J Clin Microbiol       Date:  2009-09-16       Impact factor: 5.948

9.  Pneumocystis murina infection and cigarette smoke exposure interact to cause increased organism burden, development of airspace enlargement, and pulmonary inflammation in mice.

Authors:  Paul J Christensen; Angela M Preston; Tony Ling; Ming Du; W Bradley Fields; Jeffrey L Curtis; James M Beck
Journal:  Infect Immun       Date:  2008-05-19       Impact factor: 3.441

10.  Healthcare worker occupation and immune response to Pneumocystis jirovecii.

Authors:  Renuka Tipirneni; Kieran R Daly; Leah G Jarlsberg; Judy V Koch; Alexandra Swartzman; Brenna M Roth; Peter D Walzer; Laurence Huang
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.